Clinical Trials Browser

OTHER × Pituitary ACTH Hypersecretion × Endocrine × Clear all

Pituitary Diseases, Pituitary ACTH Hypersecretion, ACTH-Secreting Pituitary Adenoma

NCT07460232 2026-03-10

FET PET/CT Imaging To Localize Pituitary Adenomas In Cushing Disease

Phase EARLY_PHASE1 Not yet recruiting

50 enrolled

Endocrine

Pituitary Neoplasms, Pituitary ACTH Hypersecretion

NCT07335315 2026-01-13

Evaluation of Intraoperative Contrast Enhanced Ultrasound for the Identification of Pituitary Adenoma in Cushing's Disease Compared to Other Pituitary Tumors

Recruiting

110 enrolled

Endocrine

Pituitary Neoplasms, Pituitary ACTH Hypersecretion

NCT05971758 2025-07-04

Fimepinostat, Combination HDAC and Pi3-kinase Inhibitor Tumor-Directed Therapy for Cushing Disease

Phase 2 Recruiting

20 enrolled

Endocrine

Pituitary ACTH Hypersecretion

NCT06701838 2024-12-03

OPTIMAL

Not yet recruiting

15 enrolled

Endocrine

Cushing Syndrome, Pituitary Neoplasms, Pituitary ACTH Hypersecretion, ACTH-Secreting Pituitary Adenoma

NCT04433819 2020-06-16

Nailfold Capillaroscopy Evaluation in Cushing Syndrome Patients

Unknown

200 enrolled

Endocrine

ACTH Syndrome, Ectopic, Cushing Syndrome, Pituitary ACTH Hypersecretion

NCT03474601 2020-03-18

SNU-PIT

Unknown

1,600 enrolled

Endocrine

Acromegaly, Pituitary Diseases, Pituitary Neoplasms, Prolactinoma, Diabetes Insipidus, Neurogenic, Pituitary ACTH Hypersecretion

NCT00889525 2009-04-29

Study of Cabergoline in Treatment of Corticotroph Pituitary Tumor

Phase 3 Completed

Endocrine

Pituitary ACTH Hypersecretion, ACTH-Secreting Pituitary Adenoma

Clinical Trials

PiTFET

FET PET/CT Imaging To Localize Pituitary Adenomas In Cushing Disease

Evaluation of Intraoperative Contrast Enhanced Ultrasound for the Identification of Pituitary Adenoma in Cushing's Disease Compared to Other Pituitary Tumors

Fimepinostat, Combination HDAC and Pi3-kinase Inhibitor Tumor-Directed Therapy for Cushing Disease

OPTIMAL

Nailfold Capillaroscopy Evaluation in Cushing Syndrome Patients

SNU-PIT

Study of Cabergoline in Treatment of Corticotroph Pituitary Tumor